431 related articles for article (PubMed ID: 29061050)
1. Temperature/pH/Enzyme Triple-Responsive Cationic Protein/PAA-b-PNIPAAm Nanogels for Controlled Anticancer Drug and Photosensitizer Delivery against Multidrug Resistant Breast Cancer Cells.
Don TM; Lu KY; Lin LJ; Hsu CH; Wu JY; Mi FL
Mol Pharm; 2017 Dec; 14(12):4648-4660. PubMed ID: 29061050
[TBL] [Abstract][Full Text] [Related]
2. Targeted Smart pH and Thermoresponsive N,O-Carboxymethyl Chitosan Conjugated Nanogels for Enhanced Therapeutic Efficacy of Doxorubicin in MCF-7 Breast Cancer Cells.
Verma NK; Purohit MP; Equbal D; Dhiman N; Singh A; Kar AK; Shankar J; Tehlan S; Patnaik S
Bioconjug Chem; 2016 Nov; 27(11):2605-2619. PubMed ID: 27643823
[TBL] [Abstract][Full Text] [Related]
3. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
Kashyap S; Singh N; Surnar B; Jayakannan M
Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
[TBL] [Abstract][Full Text] [Related]
4. Charge-conversional and reduction-sensitive poly(vinyl alcohol) nanogels for enhanced cell uptake and efficient intracellular doxorubicin release.
Chen W; Achazi K; Schade B; Haag R
J Control Release; 2015 May; 205():15-24. PubMed ID: 25445693
[TBL] [Abstract][Full Text] [Related]
5. Dual stimuli-responsive polymeric hollow nanogels designed as carriers for intracellular triggered drug release.
Chiang WH; Ho VT; Huang WC; Huang YF; Chern CS; Chiu HC
Langmuir; 2012 Oct; 28(42):15056-64. PubMed ID: 23036055
[TBL] [Abstract][Full Text] [Related]
6. Redox-responsive hyaluronic acid nanogels for hyperthermia- assisted chemotherapy to overcome multidrug resistance.
Li B; Xu Q; Li X; Zhang P; Zhao X; Wang Y
Carbohydr Polym; 2019 Jan; 203():378-385. PubMed ID: 30318226
[TBL] [Abstract][Full Text] [Related]
7. Ultrasonically assisted preparation of poly(acrylic acid)/calcium phosphate hybrid nanogels as pH-responsive drug carriers.
Li F; Xing Q; Han Y; Li Y; Wang W; Perera TSH; Dai H
Mater Sci Eng C Mater Biol Appl; 2017 Nov; 80():688-697. PubMed ID: 28866216
[TBL] [Abstract][Full Text] [Related]
8. Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer.
Wang H; Zhao Y; Wang H; Gong J; He H; Shin MC; Yang VC; Huang Y
J Control Release; 2014 Oct; 192():47-56. PubMed ID: 25003794
[TBL] [Abstract][Full Text] [Related]
9. Hierarchically Self-Assembled Supramolecular Host-Guest Delivery System for Drug Resistant Cancer Therapy.
Cheng H; Fan X; Wang X; Ye E; Loh XJ; Li Z; Wu YL
Biomacromolecules; 2018 Jun; 19(6):1926-1938. PubMed ID: 29350902
[TBL] [Abstract][Full Text] [Related]
10. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation.
Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X
Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165
[TBL] [Abstract][Full Text] [Related]
11. Novel dual stimuli-responsive ABC triblock copolymer: RAFT synthesis, "schizophrenic" micellization, and its performance as an anticancer drug delivery nanosystem.
Davaran S; Ghamkhari A; Alizadeh E; Massoumi B; Jaymand M
J Colloid Interface Sci; 2017 Feb; 488():282-293. PubMed ID: 27837719
[TBL] [Abstract][Full Text] [Related]
12. A smart tumor targeting peptide-drug conjugate, pHLIP-SS-DOX: synthesis and cellular uptake on MCF-7 and MCF-7/Adr cells.
Song Q; Chuan X; Chen B; He B; Zhang H; Dai W; Wang X; Zhang Q
Drug Deliv; 2016 Jun; 23(5):1734-46. PubMed ID: 25853477
[TBL] [Abstract][Full Text] [Related]
13. Tumor Targeting Synergistic Drug Delivery by Self-Assembled Hybrid Nanovesicles to Overcome Drug Resistance.
Gong MQ; Wu C; He XY; Zong JY; Wu JL; Zhuo RX; Cheng SX
Pharm Res; 2017 Jan; 34(1):148-160. PubMed ID: 27738951
[TBL] [Abstract][Full Text] [Related]
14. TPGS-functionalized and ortho ester-crosslinked dextran nanogels for enhanced cytotoxicity on multidrug resistant tumor cells.
Sun M; Wang X; Cheng X; He L; Yan G; Tang R
Carbohydr Polym; 2018 Oct; 198():142-154. PubMed ID: 30092984
[TBL] [Abstract][Full Text] [Related]
15. Reversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cells.
Shieh MJ; Hsu CY; Huang LY; Chen HY; Huang FH; Lai PS
J Control Release; 2011 Jun; 152(3):418-25. PubMed ID: 21435362
[TBL] [Abstract][Full Text] [Related]
16. Endosome/lysosome-detained supramolecular nanogels as an efflux retarder and autophagy inhibitor for repeated photodynamic therapy of multidrug-resistant cancer.
Zhang X; Chen X; Guo Y; Jia HR; Jiang YW; Wu FG
Nanoscale Horiz; 2020 Mar; 5(3):481-487. PubMed ID: 32118218
[TBL] [Abstract][Full Text] [Related]
17. Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer.
Jiang D; Gao X; Kang T; Feng X; Yao J; Yang M; Jing Y; Zhu Q; Feng J; Chen J
Nanoscale; 2016 Feb; 8(5):3100-18. PubMed ID: 26785758
[TBL] [Abstract][Full Text] [Related]
18. Polyacrylic acid modified upconversion nanoparticles for simultaneous pH-triggered drug delivery and release imaging.
Jia X; Yin J; He D; He X; Wang K; Chen M; Li Y
J Biomed Nanotechnol; 2013 Dec; 9(12):2063-72. PubMed ID: 24266261
[TBL] [Abstract][Full Text] [Related]
19. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
Wong HL; Bendayan R; Rauth AM; Wu XY
J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]